Thanks for sharing our study!

Thanks for sharing our study!

Thanks for sharing our study!

Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma - Nature The prodrug gliocidin effectively kills glioblastoma cells by targeting de novo purine synthesis, improving survival in mouse models.

I’m excited to share our latest study in
@natureportfolio.bsky.social on this novel compound called Gliocidin, that targets glioblastoma (#GBM), the most malignant brain tumor. #drugdiscovery #cancer #cancermetabolism
@mskcancercenter.bsky.social

www.nature.com/articles/s41...

Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma - Nature The prodrug gliocidin effectively kills glioblastoma cells by targeting de novo purine synthesis, improving survival in mouse models.

A research team from MSK’s Sloan Kettering Institute and collaborators have identified a compound called gliocidin that may have the potential to improve the survival of patients with #glioblastoma – now in @natureportfolio.bsky.social #oncSKY #medSKY
Read the study: www.nature.com/articles/s41...

Thanks for sharing our paper!